Triple-acting Lytic Enzyme Treatment of Drug-Resistant and Intracellular Staphylococcus aureus.

Sci Rep · 2016 · PMC4848530 · PMID 27121552

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

Still to be addressed are the physicochemical and pharmacokinetic aspects of PGH treatments [which are likely to be significant, considering the potential for intracellular transport].

also in 1,824 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.